
Enable job alerts via email!
Generate a tailored resume in minutes
Land an interview and earn more. Learn more
A radiopharmaceutical biotech company in Oslo seeks a skilled Scientist to join their in vitro pharmacology team. The role involves executing in vitro studies, conducting a range of assays, and collaborating with other teams. Candidates should have an MSc or PhD in a related field, hands-on experience with cell culture and pharmacology assays, and a knowledge of radioactive materials. The position offers competitive compensation and the chance to impact patient lives through innovative science.
Actithera is a radiopharmaceutical biotech company, co-headquartered in Oslo and Cambridge, Massachusetts, founded in 2021. The company applies a chemistry-first approach to design next-generation radioligand therapies (RLTs) that deliver potent, tumor-focused radiation while sparing healthy tissue—guided by an isotope-agnostic and platform-enabled strategy to optimize tumor retention and therapeutic index. Actithera’s vision is rooted in precision molecular design and a deeply collaborative culture, with a shared mission to transform the lives of cancer patients through innovative science.
We are seeking a motivated and skilled Scientist to join our in vitro pharmacology team in Oslo. This role focuses on the hands-on execution of in vitro studies to support our radiopharmaceutical discovery programs. The Scientist will perform a broad range of assays to characterize candidate compounds and generate high-quality data that advances our pipeline.
Reach out with your resume: careers@actithera.com